Why Is Moderna Stock Trading Higher On Monday?
Why Is Moderna Stock Trading Higher On Monday?
With the License in place, the facility will proceed with the final qualification process, positioning it to domestically manufacture a portfolio of mRNA vaccines against respiratory viruses beginning in 2025, including COVID-19 and, contingent on approval by Health Canada, respiratory syncytial virus (RSV), and seasonal influenza.Monday, Moderna, Inc.'s (NASDAQ:MRNA) manufacturing facility in Laval, Quebec, received a Drug Establishment License (DEL) from Health Canada.
星期一，Moderna, Inc.”s（纳斯达克股票代码：MRNA）位于魁北克省拉瓦尔的制造工厂获得了加拿大卫生部颁发的药品机构许可证（DEL）。
This certification affirms the facility's compliance with safety and quality standards, authorizing it to produce drug substances.
该认证确认了该设施符合安全和质量标准，并授权其生产药物物质。
This key milestone enables Moderna's Canadian manufacturing site to become fully operational, bringing the company closer to ensuring a reliable and onshore supply of mRNA vaccines within Canada.
这一关键里程碑使Moderna的加拿大制造基地得以全面运营，使该公司更接近于确保加拿大境内mRNA疫苗的可靠陆上供应。
With the License in place, the facility will proceed with the final qualification process, positioning it to domestically manufacture a portfolio of mRNA vaccines against respiratory viruses beginning in 2025, including COVID-19 and, contingent on approval by Health Canada, respiratory syncytial virus (RSV), and seasonal influenza.
许可证到位后，该设施将进入最终认证程序，使其能够从2025年开始在国内生产针对呼吸道病毒的mRNA疫苗组合，包括 COVID-19 以及呼吸道合胞病毒（RSV）和季节性流感（视加拿大卫生部的批准而定）。
Also Read: Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
另请阅读：动物研究显示，Moderna的研究型Mopox疫苗比目前批准的疫苗更有效
"This is a significant achievement in our efforts to bring certified end-to-end mRNA manufacturing capabilities to Canada and is the first of our manufacturing sites outside the U.S. to reach this milestone," said Stéphane Bancel, Chief Executive Officer of Moderna. "We look forward to continuing our work with the Government of Canada to support the national supply of vital respiratory vaccines."
Moderna首席执行官Stephane Bancel表示：“这是我们在为加拿大提供经过认证的端到端mRNA制造能力方面取得的一项重大成就，也是我们在美国以外第一个达到这一里程碑的制造基地。”“我们期待继续与加拿大政府合作，支持全国重要呼吸道疫苗的供应。”
"This is another landmark in Moderna's long-term strategic partnership with the Government of Canada to provide onshore respiratory vaccine manufacturing capabilities and support national pandemic readiness," said Roger Ngassam, Laval Manufacturing Site Head, Moderna Canada. "This platform will be the foundation for enabling the manufacturing of multiple mRNA vaccines right here in Canada."
加拿大摩德纳拉瓦尔制造基地负责人罗杰·恩加萨姆表示：“这是Moderna与加拿大政府建立长期战略合作伙伴关系的又一个里程碑，旨在提供陆上呼吸道疫苗生产能力并支持国家疫情防范。”“该平台将成为加拿大生产多种mRNA疫苗的基础。”
This milestone also builds on Moderna's existing manufacturing footprint, including key U.S. facilities and facilities under construction in Australia and the U.K.
这一里程碑还建立在 Moderna 现有的制造足迹基础上，包括在澳大利亚和英国建设的主要美国设施和设施。
Recently, the FDA granted emergency use authorization for updated mRNA COVID-19 vaccines (2024-2025 formula) from Moderna and Pfizer Inc (NYSE:PFE)/ BioNTech SE (NASDAQ:BNTX).
最近，美国食品药品管理局批准了莫德纳和辉瑞公司（纽约证券交易所代码：PFE）/BioNTech SE（纳斯达克股票代码：BNTX）更新的mRNA COVID-19 疫苗（2024-2025年配方）的紧急使用授权。
Price Action: MRNA stock is up 6.70% at $77.77 at the last check Monday.
价格走势：在周一的最后一次检查中，MRNA股票上涨6.70％，至77.77美元。
- Pembina Strikes Major Deal To Boost Oil And Gas Infrastructure: Details.
- 彭比纳达成重大协议以促进石油和天然气基础设施：详情。
Photo via Wikimedia Commons
照片来自维基共享资源
